Cite
HARVARD Citation
Sun, S. et al. (2022). Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A. Expert review of hematology. 15 (10), pp. 943-950. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sun, S. et al. (2022). Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A. Expert review of hematology. 15 (10), pp. 943-950. [Online].